Clinical Trials on HR+/HER2- 转移性乳腺癌 in Korea, Democratic People's Republic of
总计748个结果
-
Samsung Medical Center尚未招聘
-
Eli Lilly and Company主动,不招人胰腺癌 | 实体瘤 | 皮肤黑色素瘤 | 微卫星不稳定性高 (MSI-H) 实体瘤 | 乳腺癌 (HR+HER2-)比利时, 西班牙, 大韩民国, 美国, 台湾, 法国, 加拿大
-
Korean Cancer Study Group未知
-
National Cancer Center, Korea主动,不招人
-
Yonsei University招聘中
-
Korea University Guro HospitalKorean Cancer Study Group主动,不招人
-
Gangnam Severance HospitalSeoul National University招聘中
-
Gangnam Severance Hospital招聘中HER2 富集亚型乳腺癌,Herzuma,PAM50 研究大韩民国
-
EnhancedBio USA Inc.Zenopharm招聘中
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korean Cancer Study Group (KCSG); Eisai Korea Inc.; Ono...主动,不招人
-
Samsung Medical Center未知
-
Samsung Medical Center未知
-
Korean Breast Cancer Study Group未知
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals Corporation完全的
-
Samsung Medical Center完全的
-
Gachon University Gil Medical Center未知
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance Hospital招聘中乳腺癌 | 手术 | 复发性乳腺癌 | 雌激素受体阳性肿瘤 | 立体定向放疗 | Her2-negative Tumor大韩民国
-
Samsung Medical Center完全的
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital; Korea University... 和其他合作者未知
-
National Cancer Center, Korea终止
-
Yonsei University尚未招聘
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University... 和其他合作者未知
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Korea University... 和其他合作者未知
-
Samsung Medical Center主动,不招人
-
Samsung Medical Center招聘中
-
Samsung Medical Center完全的